Your browser doesn't support javascript.
loading
Factors associated with total laryngectomy following organ-preserving treatment of laryngeal SCC.
Victor, Mitchell T; Faraji, Farhoud; Voora, Rohith; Kalavacherla, Sandhya; Mell, Loren K; Rose, Brent S; Guo, Theresa W.
Afiliação
  • Victor MT; University of California San Diego School of Medicine San Diego California USA.
  • Faraji F; Northwestern University, Feinberg School of Medicine Chicago Illinois USA.
  • Voora R; Department of Otolaryngology-Head and Neck Surgery University of California San Diego Health La Jolla California USA.
  • Kalavacherla S; Hanna and Mark Gleiberman Head and Neck Cancer Center, Moores Cancer Center University of California San Diego Health La Jolla California USA.
  • Mell LK; Department of Otolaryngology-Head and Neck Surgery University of California San Diego Health La Jolla California USA.
  • Rose BS; University of California San Diego School of Medicine San Diego California USA.
  • Guo TW; Hanna and Mark Gleiberman Head and Neck Cancer Center, Moores Cancer Center University of California San Diego Health La Jolla California USA.
Laryngoscope Investig Otolaryngol ; 9(4): e1317, 2024 Aug.
Article em En | MEDLINE | ID: mdl-39108948
ABSTRACT

Objectives:

A subset of laryngeal squamous cell carcinoma (LSCC) patients undergoing larynx preserving treatment ultimately require total laryngectomy (TL) for oncologic or functional reasons. This study aims to identify TL risk factors in these patients.

Methods:

Retrospective cohort study using Veterans Affairs (VA) database. T1-T4 LSCC cases treated with primary radiotherapy (XRT) or chemoradiotherapy (CRT) were assessed for TL and recurrence. Binary logistic and Cox regression and Kaplan-Meier analyses were implemented.

Results:

Of 5390 cases, 863 (16.0%) underwent TL. On multivariable analysis, age (adjusted odds ratio 0.97 [0.96-0.98]; p < .001) and N3 disease (0.42 [0.18-1.00]; p = .050) were associated with reduced risk of TL, whereas current alcohol use (1.22 [1.04-1.43]; p = .015) and >T1 disease (T2, 1.76 [1.44-2.17]; p < .001; T3, 2.06 [1.58-2.68]; p < .001; T4, 1.79 [1.26-2.53]; p = .001) were associated with increased risk of TL. However, N2 (adjusted hazard ratio 1.30 [1.10-1.55]; p = .003) and N3 (2.02 [1.25-3.26]; p = .004) disease were associated with an increased risk for local recurrence. Compared to XRT, treatment with CRT was associated with reduced risk for local recurrence after adjusting for other factors (0.84 [0.70-0.99]; p = .044). Those who do not receive TL following local recurrence have poorer disease-specific survival (log-rank, p < .001). In patients without local recurrence, N2 disease was associated with a fourfold increase in risk of TL (4.24 [1.83-9.82]; p < .001).

Conclusion:

Advanced nodal stage was associated with reduced rates of salvage TL in the setting of local recurrence, and subsequent worse prognosis after recurrence. Conversely, advanced nodal stage may increase the risk for functional salvage TL in patients without recurrence. Level of Evidence Level 3.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Laryngoscope Investig Otolaryngol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Laryngoscope Investig Otolaryngol Ano de publicação: 2024 Tipo de documento: Article